FLUDEOXYGLUKOSA INJ.

Main information

  • Trade name:
  • FLUDEOXYGLUKOSA INJ. Solution for injection 100-1500MBQ/ML
  • Dosage:
  • 100-1500MBQ/ML
  • Pharmaceutical form:
  • Solution for injection
  • Administration route:
  • Intravenous use
  • Units in package:
  • 24GBQ Vial
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FLUDEOXYGLUKOSA INJ. Solution for injection 100-1500MBQ/ML
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • FLUDEOXYGLUKOSA-(18F)
  • Product summary:
  • FLUDEOXYGLUKOSA INJ.

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 88/ 320/01-C
  • EAN code:
  • 8594060811420
  • Last update:
  • 16-01-2018

22-11-2018

Neuraceq (Life Radiopharma Berlin GmbH)

Neuraceq (Life Radiopharma Berlin GmbH)

Neuraceq (Active substance: florbetaben (18F)) - Centralised - Renewal - Commission Decision (2018)7882 of Thu, 22 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2553/R/25

Europe -DG Health and Food Safety

13-7-2018

Vizamyl (GE Healthcare Ltd)

Vizamyl (GE Healthcare Ltd)

Vizamyl (Active substance: flutemetamol (18F)) - Centralised - Yearly update - Commission Decision (2018)4614 of Fri, 13 Jul 2018

Europe -DG Health and Food Safety